Cameron Flayer is a Senior Scientist at Gilead Sciences, specializing in inflammation and neuroimmunology with a focus on type 2, type 3, and B cell inflammatory pathways. Cameron completed a PhD in Pharmacology and Toxicology at the University of California, Davis, graduating in 2019, and subsequently conducted postdoctoral research at Harvard Medical School and Massachusetts General Hospital from 2019 to 2024. Cameron's career includes internships and roles as a Health Scientist and Graduate Intern at Cardno ChemRisk, as well as research assistance at Wake Forest University, illustrating a strong foundation in biological and environmental sciences. With over a decade of experience, Cameron is dedicated to developing new therapies for chronic inflammatory diseases.
This person is not in the org chart
This person is not in any teams
This person is not in any offices